viomycin

Viomycin is a member of the tuberactinomycin family of antibiotics. Viomycin also inhibits group I intron splicing and prokaryotic protein synthesis. Freezes bacterial ribosomes in either the pre- or post-translational state. Facilitates trans-cleavage of

Enviomycin (Tuberactinomycin N) is an antibacterial antibiotic utilized in researching chronic cavitary pulmonary tuberculosis [1].

Tuberactinomycins are cyclic peptide antibiotics that effectively inhibit protein synthesis in prokaryotic organisms.

Tuberactinomycin compounds are essential components in the current combination of drugs used to combat Mycobacterium tuberculosis infections. These compounds target bacterial ribosomes and function by binding RNA and disrupting bacterial protein biosynthesis. Tuberactinomycin is produced by the actinomycete [Streptomyces puniceus], which binds RNA and inhibits protein synthesis in prokaryotes as well as certain forms of RNA splicing.